Science

Precision medicine identifies key recurring mutation in head and neck cancers

Precision medicine identifies key recurring mutation in head and neck cancers

Researchers at UC San Diego School of Medicine and Moores Cancer Center report that an investigational drug candidate called tipifarnib showed promise in treating key recurring mutation in head and neck cancers.

Read More…….
EurekAlert!, the online, global news service operated by AAAS, the science society,